BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3221358)

  • 1. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats.
    Mauldin GN; Matus RE; Patnaik AK; Bond BR; Mooney SC
    J Vet Intern Med; 1988; 2(2):60-5. PubMed ID: 3221358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of advanced mammary adenocarcinoma in 14 cats.
    Jeglum KA; deGuzman E; Young KM
    J Am Vet Med Assoc; 1985 Jul; 187(2):157-60. PubMed ID: 3897157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma.
    Barber LG; Sørenmo KU; Cronin KL; Shofer FS
    J Am Anim Hosp Assoc; 2000; 36(5):416-21. PubMed ID: 10997517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline oral neoplasia: a ten-year survey.
    Stebbins KE; Morse CC; Goldschmidt MH
    Vet Pathol; 1989 Mar; 26(2):121-8. PubMed ID: 2711569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative radiation therapy outcomes for cats with oral squamous cell carcinoma (1999-2005).
    Sabhlok A; Ayl R
    Vet Radiol Ultrasound; 2014; 55(5):565-70. PubMed ID: 24766180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment.
    Gagnon J; Dervisis NG; Kitchell BE
    J Feline Med Surg; 2012 Aug; 14(8):560-5. PubMed ID: 22496148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases.
    Petrucci GN; Henriques J; Lobo L; Vilhena H; Figueira AC; Canadas-Sousa A; Dias-Pereira P; Prada J; Pires I; Queiroga FL
    Vet Comp Oncol; 2021 Dec; 19(4):714-723. PubMed ID: 33140523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of feline lymphoma using a 12-week, maintenance-free combination chemotherapy protocol in 26 cats.
    Limmer S; Eberle N; Nerschbach V; Nolte I; Betz D
    Vet Comp Oncol; 2016 Aug; 14 Suppl 1():21-31. PubMed ID: 24548273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of metastasis.
    Jeglum KA
    Vet Clin North Am Small Anim Pract; 1985 May; 15(3):659-66. PubMed ID: 3874470
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of low-dose metronomic (LDM) cyclophosphamide toxicity in cats with malignant neoplasia.
    Leo C; Stell A; Borrego J; Martinez de Merlo E; Ruess-Melzer K; Lara-Garcia A
    J Feline Med Surg; 2014 Aug; 16(8):671-8. PubMed ID: 24423814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with chemotherapy in advanced salivary gland neoplasms.
    Belani CP; Eisenberger MA; Gray WC
    Med Pediatr Oncol; 1988; 16(3):197-202. PubMed ID: 2837623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
    Simon D; Eberle N; Laacke-Singer L; Nolte I
    J Vet Intern Med; 2008; 22(2):394-400. PubMed ID: 18312554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicosis of VELCAP-C treatment of lymphoma in cats.
    Hadden AG; Cotter SM; Rand W; Moore AS; Davis RM; Morrissey P
    J Vet Intern Med; 2008; 22(1):153-7. PubMed ID: 18289303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment.
    MacEwen EG
    Cancer Metastasis Rev; 1990 Sep; 9(2):125-36. PubMed ID: 2253312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological toxicity of doxorubicin-containing protocols in dogs with spontaneously occurring malignant tumors.
    Ahaus EA; Couto CG; Valerius KD
    J Am Anim Hosp Assoc; 2000; 36(5):422-6. PubMed ID: 10997518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997).
    Zwahlen CH; Lucroy MD; Kraegel SA; Madewell BR
    J Am Vet Med Assoc; 1998 Oct; 213(8):1144-9. PubMed ID: 9787382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.
    Fox LE; Rosenthal RC; King RR; Levine PB; Vail DM; Helfand SC; MacEwen EG; Perez-Soler R; Calderwood-Mays M; Kurzman ID
    Am J Vet Res; 2000 Jul; 61(7):791-5. PubMed ID: 10895902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
    Olmsted GA; Farrelly J; Post GS; Smith J
    J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
    Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
    B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for salivary gland cancer.
    Kaplan MJ; Johns ME; Cantrell RW
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):165-70. PubMed ID: 3035459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.